and Hep-2C derive from the same tissue (human Caucasian larynx carcinoma), while Vero and BGM derive from another organ (Africa green monkey kidney). Thus, Hep-2 and Vero cell lines that we used are likely susceptible to TSV if the virus can infect Hep-2C and BGM as reported by Audelo-del-Valle et al.
The difference between our methods and those used by Audelo-delValle et al. may explain the discrepant result. If CPE occurred "usually from 19-23 hours" and "cells were then harvested and lysed" for next injection, TSV most likely persisted in the lysate after the third passage because the cell monolayers had not been washed as they were in our method. According to the time the CPE was observed and the methods of Audelodel-Valle et al., we assumed that, in their study, cells might be passaged at least three times within 1 week, whereas TSV might remain viable and infective for 1 week. Additionally, the Office International des Epizooties recommended an injection volume of 1% of shrimp body weight (8) The study was performed in the Ogooué-Ivindo province of Gabon, a country of Central Africa with an equatorial climate. Blood samples were taken from dogs in the town of Mékambo and in all villages connecting Mékambo and Mazingo (nine villages) and Mékambo and Ekata (seven villages) during July and August 2003. Each dog brought by its owner for the study was weighed and sedated by injection with 50 µg/kg of medetomidine (Pfizer Santé Animal, Orsay, France). After the dog was examined, a blood sample was drawn from the jugular vein by Vacutainer (Becton Dickinson, Meylan, France). Each dog was tattooed with an identification number and given both antihelminthic and external antiparasitic treatments. During the examination, the dogs were treated with care; upon completion of the examination, the dogs were given 250 µg/kg of the reversal agent atipamezola (Pfizer Santé Animal) intramuscularly. A physical examination form and a questionnaire were completed for each test participant by its owner. A total of 258 dogs (155 males and 103 females) were examined and had blood samples drawn during the study. All animals were of mixed breeds and were 6 months to 14 years old (average 3 years 1 month). The Vacutainer tubes were kept on ice until blood samples were dispensed into cryotubes and frozen in liquid nitrogen. Samples were stored at -80°C until isolation attempts were made on Columbia agar (Biomérieux, Marcy l'étoile, France) as described previously (2) . In this study, six Bartonella isolates were obtained and identified as B. clarridgeiae (five isolates) and B. henselae (one isolate), by internal transcribed spacer amplification and sequencing (3) .
B. vinsonii subsp. berkhoffii was the first Bartonella species found in dogs (1) . Isolation of B. clarridgeiae (4, 5) and B. washoensis (6) in dogs was recently reported. Infection of dogs by other Bartonella species was also detected in the DNA of B. henselae (7, 8) , B. clarridgeiae (7) , and B. elizabethae (8) . The presence of these Bartonella species is not surprising, since Ctenocephalides felis, the vector of B. henselae in cats, has a wide range of hosts, including the domestic dog. However, attempts to isolate this species in samples collected from 211 dogs in the United Kingdom failed (9) . Bartonella species are supposedly difficult to isolate in dogs because of a low concentration of bacteria in the blood (1). This supposition was apparent in our study; we identified approximately 100 bacterial colonies per milliliter of blood from three of the six dogs in our study. From the other three dogs in our study, including the dog infected with B. henselae, we identified two to four bacterial colonies per milliliter of blood.
Most of the data pertaining to Bartonella have been obtained in the United States and Europe. Increasingly, Bartonella infections are being reported in Africa, especially in southern Africa (10 
